Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Inspire Medical Systems Inc. (INSP)

  • Event
  • Nov. 11, 2022, 01:05 UTC
  • 122
  • 0 comments

Inspire Sleep - Stifel 2022 Healthcare Conference

Comment Full text

QuantumSi Inc (QSI)

  • Event
  • Nov. 11, 2022, 00:44 UTC
  • 125
  • 0 comments

New Form S-8 for Quantum-Si Incorporated

Comment Full text

QuantumSi Inc (QSI)

  • Event
  • Nov. 11, 2022, 00:21 UTC
  • 131
  • 0 comments

New Form 4 for Quantum-Si Incorporated

Comment Full text

Rain Therapeutics Inc (RAIN)

  • Event
  • Nov. 11, 2022, 00:06 UTC
  • 129
  • 0 comments

Rain Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Progress

Comment Full text

Aeglea BioTherapeutics Inc (AGLE)

  • Event
  • Nov. 11, 2022, 00:04 UTC
  • 129
  • 0 comments

Aeglea BioTherapeutics Inc. - Aeglea BioTherapeutics Corporate Presentation

Comment Full text

Evolus Inc (EOLS)

  • Event
  • Nov. 10, 2022, 19:23 UTC
  • 124
  • 0 comments

Evolus - November 2022 Investor Presentation

Comment Full text

Equillium Inc. (EQ)

  • Event
  • Nov. 10, 2022, 18:26 UTC
  • 131
  • 0 comments

Equillium - Equillium Corporate Presentation

Comment Full text

Moderna Inc (MRNA)

  • Event
  • Nov. 10, 2022, 16:55 UTC
  • 129
  • 0 comments

Moderna - Moderna ESG Day

Comment Full text

Genmab (GMAB)

  • Event
  • Nov. 10, 2022, 16:28 UTC
  • 124
  • 0 comments

Genmab to Present at Jefferies London Healthcare Conference

Comment Full text

Passage Bio Inc (PASG)

  • Event
  • Nov. 10, 2022, 15:03 UTC
  • 126
  • 0 comments

Passage Bio, Inc. - Corporate Presentation - November 2022

Comment Full text
  • Previous
  • 86
  • 87
  • 88
  • 89
  • 90
  • Next

Search

News categories

  • Technical Exchange News(10868)
  • Event(2238)
  • SEC News(188884)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124452)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin